OTC Import Alerts Could Grow Due To PREDICT Requirements
This article was originally published in The Tan Sheet
Executive Summary
PREDICT eventually will help low-risk importers because data will drive the system to not flag those firms, easing the import process. Firms should work hard to stay off the import alert list, which prompts closer scrutiny and can lead to delays.
You may also be interested in...
PREDICT Helps FDA Answer Appropriators' Call To Facilitate Imports
The PREDICT information technology system should help FDA comply with the intent, if not the particulars, of a House Appropriations Committee suggestion to facilitate imports of goods that pose little risk.
People In Brief
Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.
FDA Details “Quality Agreements” For Marketers, Contract Manufacturers
The “Contract Manufacturing Arrangements for Drugs: Quality Agreements” draft guidance describes how parties involved in contract manufacturing of drugs can employ quality agreements to delineate their responsibilities and ensure drug quality, safety and efficacy.